Hummingbird Diagnostics GmbH
PrivateLast Round
Grant
Apr 29, 2020
Total Funding Raised
$708,382
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hummingbird Diagnostics GmbH is a biotechnology company that develops small RNA-based blood tests for the early detection and characterization of diseases, with an initial focus on lung cancer and Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hummingbird Diagnostics GmbH Comparables
Compare Hummingbird Diagnostics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exai Bio | 80% | |
| Flomics Biotech | 79% | |
| Aptorum Group Limited | 78% |
Hummingbird Diagnostics GmbH Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Hummingbird Diagnostics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreyBird Ventures | VC Round, Seed |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 40% MoM, reaching 450.
- Feb 4, 2026
Monthly visitors increased 347% MoM.
Recent news
Latest coverage and updates
- attends_eventSep 30, 2026
Hummingbird Diagnostics GmbH is to present blood-based RNA biomarker data at ESMO 2026 in Spain
Hummingbird Diagnostics GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hummingbird Diagnostics GmbH's valuation, stock price, and market status.
Is Hummingbird Diagnostics GmbH a public or private company?
Hummingbird Diagnostics GmbH is a private company.
What is the current stock price of Hummingbird Diagnostics GmbH?
Hummingbird Diagnostics GmbH is a private company, so its shares have no public market price. Caplight tracks Hummingbird Diagnostics GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hummingbird Diagnostics GmbH worth (valuation)?
Valuation information for Hummingbird Diagnostics GmbH is not publicly available.
Can I buy Hummingbird Diagnostics GmbH stock?
Hummingbird Diagnostics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hummingbird Diagnostics GmbH's last funding round?
Hummingbird Diagnostics GmbH's most recent funding round was Grant on April 29, 2020.
Who are the main investors in Hummingbird Diagnostics GmbH?
Key investors in Hummingbird Diagnostics GmbH include GreyBird Ventures, Alzheimer's Drug Discovery Foundation.
Will Hummingbird Diagnostics GmbH IPO soon?
No public IPO plans have been announced for Hummingbird Diagnostics GmbH.
How can I track Hummingbird Diagnostics GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Hummingbird Diagnostics GmbH's shares on secondary markets.